Our Mission
Ken Malone, one of our co-founders, describes the uniqueness of Early Charm Ventures:
We are the management team, the operators, and the entrepreneurs. We don’t just write checks and pop in for board meetings. We show up to our labs, our production facilities, and our offices every day to do all the heavy lifting for our portfolio companies.
Our scientists and engineers work across our entire portfolio, never just for one venture. This brings extraordinary expertise to the earliest stages of product development. The lack of silos fosters creativity and attracts the most collaborative people.
Our Ventures
Synergy with our existing ventures is important to us, so we look for opportunities that fit with our current capabilities in Drug Design, Blue Economy, Advanced Materials, and Engineered Products.
Because synergy between our companies is so strong, the individual companies are seldom as valuable alone than as a part of the whole. Thus, we aren’t focused on exit strategies and quick flips. We are focused on building sustainable businesses through revenue, and on expanding opportunities by retaining our team.
Our Ventures
Synergy with our existing ventures is important to us, so we look for opportunities that fit with our current capabilities in Drug Design, Blue Economy, Advanced Materials, and Engineered Products.
Because synergy between our companies is so strong, the individual companies are seldom as valuable alone than as a part of the whole. Thus, we aren’t focused on exit strategies and quick flips. We are focused on building sustainable businesses through revenue, and on expanding opportunities by retaining our team.
Latest News
Optave Diagnostics Awarded $256,000 in SBIR Phase I Funding for Prostate Cancer Diagnostic Medical Device Development
Optave Diagnostics, a technology company developing an endoscopic probe device that uses photoacoustic imaging (PAI) to aid in cancer detection and diagnosis, today announced it has been awarded a $256,000 Small Business Innovation Research (SBIR) Phase I grant from the National Science Foundation (NSF).
Rashi Sultania Joins Early Charm Ventures as Research Associate with Focus on Drug Design and Advanced Materials
Early Charm Ventures, a company that creates, owns and operates ventures that convert science to revenue, today welcomed Rashi Sultania – a chemical and biomolecular engineer – as Research Associate focusing on R&D and product development for Early Charm’s advanced materials and drug design portfolio of companies.
Early Charm Ventures Announces Hiring of Anthony Benter as Executive Assistant
Early Charm Ventures, a company that creates, owns and operates ventures that convert science to revenue, today announced the hiring of Anthony Benter – an experienced business administrator with skills in sales, personnel management and accounting – as Executive Assistant.
Technical and Support Partners
Our collaborators include government, academic, and industrial organizations.
